Literature DB >> 32938199

Effect of Gender on Clinical Outcomes in Patients Receiving CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Chelsea Gustafson1, Megan N Gower2, Alexis K Williams2, Eric Pauley1, Karen E Weck3, Craig R Lee2,4, George A Stouffer1,4.   

Abstract

Entities:  

Keywords:  acute coronary syndrome; clopidogrel; percutaneous coronary intervention; prasugrel; sex; ticagrelor

Year:  2020        PMID： 32938199      PMCID： PMC7578089          DOI： 10.1161/CIRCGEN.120.003023

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN： 2574-8300


× No keyword cloud information.
  5 in total

1.  Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.

Authors:  Melissa D Klein; Alexis K Williams; Craig R Lee; George A Stouffer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

2.  A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.

Authors:  Daniel M F Claassens; Gerrit J A Vos; Thomas O Bergmeijer; Renicus S Hermanides; Arnoud W J van 't Hof; Pim van der Harst; Emanuele Barbato; Carmine Morisco; Richard M Tjon Joe Gin; Folkert W Asselbergs; Arend Mosterd; Jean-Paul R Herrman; Willem J M Dewilde; Paul W A Janssen; Johannes C Kelder; Maarten J Postma; Anthonius de Boer; Cornelis Boersma; Vera H M Deneer; Jurriën M Ten Berg
Journal:  N Engl J Med       Date:  2019-09-03       Impact factor: 91.245

3.  Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Authors:  Craig R Lee; Vindhya B Sriramoju; Alexandra Cervantes; Lucius A Howell; Nicholas Varunok; Shivanshu Madan; Kasey Hamrick; Melissa J Polasek; John Andrew Lee; Megan Clarke; Jonathan D Cicci; Karen E Weck; George A Stouffer
Journal:  Circ Genom Precis Med       Date:  2018-04

4.  Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Authors:  Larisa H Cavallari; Craig R Lee; Amber L Beitelshees; Rhonda M Cooper-DeHoff; Julio D Duarte; Deepak Voora; Stephen E Kimmel; Caitrin W McDonough; Yan Gong; Chintan V Dave; Victoria M Pratt; Tameka D Alestock; R David Anderson; Jorge Alsip; Amer K Ardati; Brigitta C Brott; Lawrence Brown; Supatat Chumnumwat; Michael J Clare-Salzler; James C Coons; Joshua C Denny; Chrisly Dillon; Amanda R Elsey; Issam S Hamadeh; Shuko Harada; William B Hillegass; Lindsay Hines; Richard B Horenstein; Lucius A Howell; Linda J B Jeng; Mark D Kelemen; Yee Ming Lee; Oyunbileg Magvanjav; May Montasser; David R Nelson; Edith A Nutescu; Devon C Nwaba; Ruth E Pakyz; Kathleen Palmer; Josh F Peterson; Toni I Pollin; Alison H Quinn; Shawn W Robinson; Jamie Schub; Todd C Skaar; D Max Smith; Vindhya B Sriramoju; Petr Starostik; Tomasz P Stys; James M Stevenson; Nicholas Varunok; Mark R Vesely; Dyson T Wake; Karen E Weck; Kristin W Weitzel; Russell A Wilke; James Willig; Richard Y Zhao; Rolf P Kreutz; George A Stouffer; Philip E Empey; Nita A Limdi; Alan R Shuldiner; Almut G Winterstein; Julie A Johnson
Journal:  JACC Cardiovasc Interv       Date:  2017-11-01       Impact factor: 11.195

5.  Efficacy and Safety of High Potent P2Y12 Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex-Specific Systematic Review and Meta-Analysis.

Authors:  Michelle M Schreuder; Ricardo Badal; Eric Boersma; Maryam Kavousi; Jolien Roos-Hesselink; Jorie Versmissen; Loes E Visser; Jeanine E Roeters van Lennep
Journal:  J Am Heart Assoc       Date:  2020-02-17       Impact factor: 5.501
  5 in total
  1 in total

1.  Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.

Authors:  Mina Madan; J Dawn Abbott; Ryan Lennon; Derek Y F So; Andrea M MacDougall; Mary Ann McLaughlin; Vishakantha Murthy; Jacqueline Saw; Charanjit Rihal; Michael E Farkouh; Naveen L Pereira; Shaun G Goodman
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.